Megan S Johnson
Overview
Explore the profile of Megan S Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen K, Karlawish J, Roberts J, Uhlmann W, Harkins K, Wood E, et al.
Alzheimers Dement (N Y)
. 2020 Mar;
6(1):e12002.
PMID: 32211507
Introduction: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E () genotyping is unknown. Methods: We randomized 114 individuals with MCI...
2.
Habibi J, Aroor A, Das N, Manrique-Acevedo C, Johnson M, Hayden M, et al.
Cardiovasc Diabetol
. 2019 Mar;
18(1):40.
PMID: 30909895
Objective: Diabetic nephropathy (DN) is characterized by glomerular and tubulointerstitial injury, proteinuria and remodeling. Here we examined whether the combination of an inhibitor of neprilysin (sacubitril), a natriuretic peptide-degrading enzyme,...
3.
Aroor A, Sowers J, Bender S, Nistala R, Garro M, Mugerfeld I, et al.
Endocrinology
. 2013 May;
154(7):2501-13.
PMID: 23653460
Diastolic dysfunction is a prognosticator for future cardiovascular events that demonstrates a strong correlation with obesity. Pharmacological inhibition of dipeptidylpeptidase-4 (DPP-4) to increase the bioavailability of glucagon-like peptide-1 is an...
4.
Demarco V, Ford D, Henriksen E, Aroor A, Johnson M, Habibi J, et al.
Endocrinology
. 2012 Nov;
154(1):159-71.
PMID: 23142808
Obesity and a nondipping circadian blood pressure (BP) pattern are associated with diastolic dysfunction. Ectopic lipid accumulation is increasingly recognized as an important metabolic abnormality contributing to diastolic dysfunction. However,...
5.
Demarco V, Johnson M, Ma L, Pulakat L, Mugerfeld I, Hayden M, et al.
Am J Physiol Heart Circ Physiol
. 2012 Feb;
302(8):H1667-82.
PMID: 22345570
The statistical association between endurance exercise capacity and cardiovascular disease suggests that impaired aerobic metabolism underlies the cardiovascular disease risk in men and women. To explore this connection, we applied...
6.
Johnson M, Demarco V, Heesch C, Whaley-Connell A, Schneider R, Rehmer N, et al.
Am J Physiol Heart Circ Physiol
. 2011 Aug;
301(4):H1540-50.
PMID: 21821781
The aim of this investigation was to evaluate sex differences in baroreflex and heart rate variability (HRV) dysfunction and indexes of end-organ damage in the TG(mRen2)27 (Ren2) rat, a model...
7.
Demarco V, Johnson M, Habibi J, Pulakat L, Gul R, Hayden M, et al.
Am J Physiol Heart Circ Physiol
. 2010 Nov;
300(1):H181-90.
PMID: 21057043
Telmisartan, an angiotensin receptor blocker, may have unique benefits as it possesses partial peroxisome proliferator-activated receptor (PPAR)-γ agonist activity in addition to antihypertensive effects. In this study, we test whether...
8.
Lastra G, Dhuper S, Johnson M, Sowers J
Nat Rev Cardiol
. 2010 Aug;
7(10):577-84.
PMID: 20697411
Hypertension and type 2 diabetes mellitus (T2DM) are powerful risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), both of which are leading causes of morbidity and mortality...
9.
Demarco V, Johnson M, Whaley-Connell A, Sowers J
Curr Hypertens Rep
. 2010 Apr;
12(2):93-8.
PMID: 20424939
The cardiometabolic syndrome comprises a cluster of risk factors, including abdominal obesity, dyslipidemia, hypertension, insulin resistance/glucose intolerance, and proteinuria. This syndrome is due, in part, to the accumulation of visceral...
10.
Whaley-Connell A, Johnson M, Sowers J
Prog Cardiovasc Dis
. 2010 Mar;
52(5):401-9.
PMID: 20226958
The prevalence of diabetes, hypertension, and cardiovascular disease (CVD) and chronic kidney disease (CKD) is increasing in concert with obesity. Insulin resistance, metabolic dyslipidemia, central obesity, albuminuria. and hypertension commonly...